| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,670 |
3,105 |
$114K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
136 |
121 |
$5K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
23 |
22 |
$1K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
422 |
412 |
$265.08 |
| 93000 |
|
28 |
28 |
$120.86 |
| 36415 |
Collection of venous blood by venipuncture |
594 |
577 |
$55.89 |
| 99497 |
|
25 |
25 |
$48.65 |
| 81002 |
|
59 |
57 |
$23.38 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
227 |
199 |
$17.14 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
16 |
16 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
32 |
32 |
$0.00 |
| 82044 |
|
12 |
12 |
$0.00 |
| 99080 |
|
318 |
74 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
16 |
16 |
$0.00 |